Berkshire, United Kingdom

Enda Elizabeth Clarke


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Berkshire, GB (2005)
  • London, GB (2005)

Company Filing History:


Years Active: 2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Enda Elizabeth Clarke: Innovator in Virulence Gene Research

Introduction

Enda Elizabeth Clarke is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of microbiology, particularly in the study of virulence genes and their applications in vaccine development. With a total of 2 patents to his name, Clarke's work has the potential to impact therapeutic approaches to infectious diseases.

Latest Patents

Clarke's latest patents include "Virulence genes, proteins, and their use" and "Virulence genes and proteins, and their use." The first patent describes a series of genes that encode products implicated in virulence, allowing for the production of attenuated microorganisms. This identification is crucial for the manufacture of vaccines aimed at therapeutic applications. The second patent focuses on the identification of virulence genes in K1, which may play a role in the pathogenicity of certain organisms. The expressed products of these genes can be utilized in various ways to treat infections.

Career Highlights

Throughout his career, Clarke has worked with several companies, including Microscience Limited and Vmax Ltd. His experience in these organizations has contributed to his expertise in the field of microbiology and the development of innovative solutions for health-related challenges.

Collaborations

Clarke has collaborated with notable individuals in his field, including David William Holden and Jacqueline Elizabeth Shea. These partnerships have likely enhanced his research and contributed to the advancement of his inventions.

Conclusion

Enda Elizabeth Clarke's work in the identification and application of virulence genes positions him as a significant figure in microbiological research. His patents reflect a commitment to advancing therapeutic options for infectious diseases, showcasing the importance of innovation in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…